Written Question·Department of Health and Social Care·UIN 53390

Ritlecitinib: Alopecia

Tabled: 19 May 2025

Answered: 2 June 2025

Named Day

Question

Graeme Downie

To ask the Secretary of State for Health and Social Care, what guidance his Department provides to health boards on whether they should consider (a) the mental health impacts of alopecia and (b) other factors prior to prescribing Ritlecitinib.

Answer

Karin Smyth

The National Institute for Health and Care Excellence (NICE) is the independent body that makes recommendations for the National Health Service in England on the use of new medicines, based on an assessment of clinical and cost effectiveness. The NHS in E...

ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 53390) →